Induction of unresponsiveness against IgA in IgA-deficient patients on subcutaneous immunoglobulin infusion therapy.
about
International Consensus Document (ICON): Common Variable Immunodeficiency DisordersUse of intravenous immunoglobulin in pediatric practiceSubcutaneous immunoglobulin replacement therapy in the treatment of patients with primary immunodeficiency disease.Subcutaneous immunoglobulin-g replacement therapy with preparations currently available in the United States for intravenous or intramuscular use: reasons and regimens.On the dark side of therapies with immunoglobulin concentrates: the adverse eventsImmunoglobulin therapy: history, indications, and routes of administration.Subcutaneous immunoglobulin therapy: a new option for patients with primary immunodeficiency diseases.Immunoglobulin replacement therapy in children.The use of i.v. IG therapy in dermatology.Home-based subcutaneous immunoglobulin versus hospital-based intravenous immunoglobulin in treatment of primary antibody deficiencies: systematic review and meta analysis.Subcutaneous immunoglobulins: product characteristics and their role in primary immunodeficiency disease.Current treatment options with immunoglobulin G for the individualization of care in patients with primary immunodeficiency disease.Managing patients with side effects and adverse events to immunoglobulin therapy.Anaphylaxis to IVIG.High dose subcutaneous immunoglobulin for idiopathic inflammatory myopathies and dysimmune peripheral chronic neuropathies treatment: observational study of quality of life and tolerance.Long-Term Treatment and Transfusion of Normal Blood Components Following Tolerance Induction in Patients with Anti-IgA Anaphylactic Reactions.Safe and effective use of chromatographically purified intravenous immunoglobulin despite profound anti-IgA sensitization.Successful liver and lung transplantation in patients with severe IgA deficiency, high anti-IgA concentration and a history of anaphylactic transfusion reaction.Immune tolerance induction in patients with IgA anaphylactoid reactions following long-term intravenous IgG treatment.
P2860
Q26777304-857F541A-B174-47E8-9E6C-9BA599C9FD1DQ27011481-BFD71FA6-0C2E-43BF-8D35-6B945325E21FQ33635013-223D190C-F0D5-4F64-A305-325885F7A00EQ33878939-15D099AF-CD1C-4F3C-ADFB-AE8F49C32086Q35053458-71A4D729-FEDA-40B5-8387-E3E3ADF18F70Q35685969-6C198988-0B3A-4506-9517-7CA11848AB6EQ36196688-C14B58EA-A18C-4AA2-A91F-AE0312B42576Q36979273-3131D12E-170D-49F3-BFF2-763244AD1410Q36986054-6669F493-3C4D-416E-A662-B3F172BB5F1BQ38021422-6970F86F-C2F4-4E04-844E-3D7509B4BB93Q38065205-5B288704-3410-4E5F-B7FF-FBC6D1DAF221Q38266635-478FF084-4719-4A0E-99B6-311ADA64E765Q38614953-29F08F0C-33A4-4751-A156-3D9CA598FD1CQ38895622-FBB6DD55-AFA6-41A6-9823-312A7A6D2152Q39604919-39FAE745-3F93-42C6-AAD5-21576C10B304Q41808658-A8EA6002-87F5-44F4-B124-69F1C24EAB6DQ49281951-42991AF7-AD2C-427C-86AE-F740E4A64732Q50464340-2811B373-B688-45CD-96AE-39B4F1AC7C78Q52920531-DC04E4C0-9F00-49BD-861A-0A83D5B8A964
P2860
Induction of unresponsiveness against IgA in IgA-deficient patients on subcutaneous immunoglobulin infusion therapy.
description
1998 nî lūn-bûn
@nan
1998年の論文
@ja
1998年学术文章
@wuu
1998年学术文章
@zh
1998年学术文章
@zh-cn
1998年学术文章
@zh-hans
1998年学术文章
@zh-my
1998年学术文章
@zh-sg
1998年學術文章
@yue
1998年學術文章
@zh-hant
name
Induction of unresponsiveness ...... munoglobulin infusion therapy.
@en
Induction of unresponsiveness ...... munoglobulin infusion therapy.
@nl
type
label
Induction of unresponsiveness ...... munoglobulin infusion therapy.
@en
Induction of unresponsiveness ...... munoglobulin infusion therapy.
@nl
prefLabel
Induction of unresponsiveness ...... munoglobulin infusion therapy.
@en
Induction of unresponsiveness ...... munoglobulin infusion therapy.
@nl
P2860
P1476
Induction of unresponsiveness ...... munoglobulin infusion therapy.
@en
P2860
P304
P356
10.1046/J.1365-2249.1998.00571.X
P577
1998-05-01T00:00:00Z